Healthcare entity
health-it is the sole category represented across all 2 tracked stories. Arm's-length lenders is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 116-day span.
Last mentioned: Jun 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
health-it is the sole category represented across all 2 tracked stories. Arm's-length lenders is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 116-day span. Their average consequence score of 5 runs below the beat's 6 for that window. Source depth averages 3 original sources per story, versus 3.3 across the same-window beat baseline. This profile follows 2 Healthcare stories mentioning DIAGNOS Inc. across the period from February 26, 2026 to June 21, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 619 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DIAGNOS Inc.. Shared-story counts are live from our verified record — not editorial picks.
Share Hold Period Expires
Four-month-and-one-day hold period ends, allowing newly issued shares to be freely traded, subject to securities laws.
Anticipated Settlement Date
Settlement expected to close, with 625,000 shares issued and accrued interest paid in cash.
Debt-for-Equity Agreements Signed
DIAGNOS signs agreements with two lenders to settle C$125,000 in demand loans via equity issuance.
Market Reporting
Financial news outlets and analysts begin reporting on the company's performance.
Earnings Release
DIAGNOS Inc. issues financial results for the latest fiscal period.
Strategic Expansion
Ongoing rollout of the CARA platform in international markets including Saudi Arabia and Mexico.
Diagnos Inc. converts C$125K in debt to equity, preserving cash to further develop its AI-powered early detection of eye-related health issues. The move underscores the financial pressures on health AI startups but keeps the clinical mission on track.
Source: shorelinebeacon.com · pembrokeobserver.com
DIAGNOS Inc. (OTCMKTS: DGNOF) has released its latest financial results, highlighting the company's ongoing efforts to scale its AI-driven retinal screening platform. The results come as the healthcare industry increasingly adopts automated diagnostic tools to address the global rise in diabetic retinopathy and other vision-threatening conditions.
Source: themarketsdaily.com · tickerreport.com
DIAGNOS Inc. is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
